Lumibird jumped 6% after reporting net income of 0.5 million euros for the first half of 2023, compared with 1.2 million a year earlier, but with EBITDA margin improving by 0.9 points to 14.2%.

Sales for the laser technology specialist came to €97.2 million, up 16% (+17% on a like-for-like basis), including increases of 19% for the Photonics division and 13% for the Medical division.

Lumibird is maintaining its objectives for the year, i.e. organic growth in excess of 8% per annum on the scope of consolidation to the end of 2022, and an EBITDA margin (excluding Convergent Photonics) in excess of 20%, taking into account strong seasonality.

Copyright (c) 2023 CercleFinance.com. All rights reserved.